Stay updated on Phase 2 AMEERA-4 Clinical Trial
Sign up to get notified when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.

Latest updates to the Phase 2 AMEERA-4 Clinical Trial page
- Check3 days agoChange DetectedThe study record shows an updated Last Update Posted date (2025-09-18) and related QC entries. No changes were made to the trial design, eligibility criteria, or outcome measures.SummaryDifference0.4%

- Check32 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check39 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check46 days agoChange DetectedAdds recent dates and a new Sanofi ACT16106 plain-language results link; removes older 2022 dates and a generic last update line, signaling a move toward current information and additional guidance.SummaryDifference1%

- Check53 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a maintenance update to core content. The 'Back to Top' link was removed, a minor UI change with low significance.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to Phase 2 AMEERA-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.